VA's New Antidepressant Rules; App Aids Schizophrenia; Diet And Depression
AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

For listenersOffer from Amazon

Turn quiet afternoons into listening time

  • Thousands of audiobooks, podcasts and originals
  • Listen on your phone, tablet or Echo — also offline
  • Cancel anytime
Try Audible free Free trial for new members
As an affiliate, we earn on qualifying purchases.

A new Veterans Affairs policy for younger veterans will require signed consent and documented discussions of antidepressant risks and benefits before a prescription. Separate studies reported that an investigational smartphone app reduced schizophrenia negative-symptom severity and that cutting ultraprocessed foods was linked to lower depression and anxiety scores in a small pilot trial.

The Department of Veterans Affairs will require younger veterans to sign consent forms and have documented discussions of antidepressant risks and benefits before receiving a prescription, according to a report cited by MedPage Today on September 30, 2026. The roundup also highlights an investigational app that reduced negative-symptom severity in schizophrenia in a randomized trial and a small diet study that linked fewer ultraprocessed foods with lower depression and anxiety scores.

The VA policy applies to younger veterans, but the cited report does not specify the age range, when the requirement takes effect or which antidepressants are covered. The stated requirements are a signed consent form and a record that a clinician discussed the potential risks and benefits before prescribing. The source attributes the policy details to The New York Times; it does not provide the VA’s own explanation or the exact consent language.

The schizophrenia finding comes from a randomized trial reported in JAMA Network Open. The app was investigational, and the trial showed reduced severity of negative symptoms. The roundup does not name the app, report the size of the effect, give the trial’s duration or say whether the improvement continued after the study ended. Negative symptoms are one dimension of schizophrenia symptoms, but the supplied report does not describe effects on other symptoms or day-to-day functioning.

A separate small pilot crossover trial, also reported in JAMA Psychiatry, involved patients with major depressive disorder. Participants had lower depression and anxiety scores when they reduced ultraprocessed foods, according to the roundup. The finding is an association observed within a small study, not evidence that a dietary change treats depression or can replace clinical care. The source does not provide participant numbers, the length of each diet period or the score differences.

At a glance
reportWhen: Reported September 30, 2026; the VA pol…
The developmentA psychiatry news roundup reports a new VA antidepressant consent policy alongside trial findings on a schizophrenia app and diet changes among people with depression.

Consent and New Care Options

The VA requirement makes documented discussion and signed consent part of antidepressant prescribing for the group covered by the policy. That may make the exchange about risks and benefits more formal, but the available account does not establish how the rule will change prescribing, access to treatment or patient outcomes. Its practical reach depends on details such as the age cutoff and implementation date, which are not provided.

The two research findings point to different areas under study: digital support for schizophrenia and diet as a possible influence on depression-related scores. Both may interest patients and clinicians looking for additional ways to support care. But the app remains investigational, while the diet result comes from a small pilot trial. Neither finding, as reported here, establishes a broadly effective intervention or supports changing an individual’s treatment without professional guidance.

Together, the items show why evidence strength and scope matter in mental health reporting. A policy requirement is a concrete administrative change, while early trial results are preliminary research findings. Readers should not treat the study summaries as proof of effectiveness beyond the populations and outcomes actually examined.

Products Worth Considering

As an affiliate, we earn on qualifying purchases.

Three Developments, Different Evidence

MedPage Today presented the items as part of a psychiatry news roundup dated September 30, 2026, rather than as one coordinated policy or research announcement. The VA item was attributed to The New York Times. The app and diet findings were attributed to papers in JAMA Network Open and JAMA Psychiatry, respectively. Those distinct sources and study designs matter: the policy concerns prescribing procedure, while the trials examine specific interventions and measured outcomes.

The roundup also included other mental health news, including a CDC figure that about 49,000 people in the United States died by suicide in 2023, compared with about 23,000 homicide deaths that year, citing the Morbidity and Mortality Weekly Report. That national statistic is separate from the VA rule and the two studies; it does not show that the policy or research findings affect suicide rates. The three developments covered in this article should likewise be understood separately rather than as evidence of a single trend.

“An investigational smartphone app reduced the severity of negative symptoms in schizophrenia.”

— MedPage Today’s summary of the JAMA Network Open randomized trial

Policy Scope and Trial Limits

For the VA policy, the available report leaves unanswered who qualifies as younger, when the rule begins, whether exceptions apply and what form the documented discussion must take. It also does not explain how the requirement will be monitored or whether the VA has published formal guidance.

For the app study, the roundup does not identify the app or provide the number of participants, effect size, comparison details or follow-up period. Those details are needed to judge how meaningful and lasting the result may be. The summary also does not say whether the app is available to patients outside the trial.

For the diet study, the term “small pilot” signals that the evidence is preliminary. The source does not report the sample size, exact dietary changes or duration, and it does not establish whether lower scores persisted. The reported finding cannot determine whether the same result would occur across a larger or more varied group of patients.

Awaiting Policy and Study Details

The next information to watch for is the VA’s formal policy guidance, including its age range, start date, covered prescriptions and instructions for clinicians. Until those details are available, the reported requirement can be described, but its reach and day-to-day effects remain uncertain.

For the research, fuller trial reports and follow-up studies would clarify the app’s effect, safety, usability and durability, as well as whether the diet finding holds in larger groups and over longer periods. The roundup does not announce a timetable for further studies or regulatory review of the app. Patients should discuss medication, app-based care or diet changes with a qualified health professional rather than treating these early findings as individual medical advice.

Key Questions

What does the new VA antidepressant policy require?

According to the report cited by MedPage Today, younger veterans will need to sign consent forms and have documented discussions with clinicians about antidepressant risks and benefits before receiving a prescription. The age range and effective date were not provided.

Does the schizophrenia app have confirmed long-term benefits?

The roundup reports that an investigational app reduced negative-symptom severity in a randomized trial. It gives no information about long-term outcomes, effect size or availability, so lasting benefit has not been established by the supplied report.

Does the diet study show that avoiding ultraprocessed foods treats depression?

No. A small pilot crossover trial found lower depression and anxiety scores when participants with major depressive disorder reduced ultraprocessed foods. The summary does not establish that this change treats depression or replaces professional care.

When will the VA rule take effect?

The source material does not state an effective date. Further VA guidance would be needed to confirm when clinicians must follow the requirement and which patients it covers.

Source: rss

This article is for informational purposes only and is not medical advice. Always consult a qualified healthcare professional about your specific situation.
You May Also Like

Tossing And Turning At Night? Run Through This Physiologist’s Five-point Sleep Checklist To Finally Nod Off

Physiologist Oli Patrick recommends five sleep habits, from keeping regular hours to getting morning light. The advice is not a guarantee of better sleep.

Scientists Discover How Deep Sleep Builds Muscle, Burns Fat, And Boosts The Brain

A mouse study in Cell maps brain circuits linking sleep stages, growth hormone release and wakefulness, but human health effects remain untested.

“We Have To Separate The Number On The Scale From The Assessment Of Our Health”—a Trainer Who Owns A Longevity Clinic Shares The Weekly Workout Routine She Follows

Trainer Amanda Lim shares a week of strength, cardio and recovery, and argues that scale weight alone is not a measure of health.

Skilled Nursing Dealbook: Two Hospital Systems Selling Their Nursing Homes, Including A 99-Bed Facility In Missouri

Strawberry Fields REIT bought Missouri’s 99-bed Living Center; ArchCare plans to sell Ferncliff in New York, pending state approval.